MedTrace Logo

Establishment of NAFLD Cohort and Development of Fibrosis Markers

NCT02206841 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-05-15

No results posted yet for this study

Summary

This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis.

Conditions

  • Fibrosis of Liver

Interventions

PROCEDURE

Liver biopsy

Percutaneously liver biopsy will be performed for evaluate steatosis and fibrosis.

DEVICE

ARFI

Acoustic radiation force impulse (ARFI) imaging will be performed for evaluate fibrosis of liver.

DEVICE

SWE

Supersonic shear wave elastography (SWE) will be performed for evaluate fibrosis of liver.

DEVICE

Transient elastography

Transient elastography will be performed for evaluate fibrosis of liver.

Sponsors & Collaborators

  • Seoul National University Boramae Hospital

    lead OTHER

Principal Investigators

  • Won Kim, Professor · SMG-SNU Boramae Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02206841 on ClinicalTrials.gov